SeaStar Medical Holding Corporation ICU 深 沪
已收盘 05-22 16:00:00 美东时间
3.75
-0.210
-5.30%
华盛通- 最 高4.25
- 今 开4.055
- 成交量 13.76万股
- 最 低 3.72
- 昨 收 3.96
- 总市值 1498.88万
- 52周最高 13.00
- 市盈率 静 --
- 换手率 3.44%
- 52周最低 2.07
- 委 比 88.57%
- 总股本 399.70万
- 历史最高 3050.00
- 量 比 3.05
- 振 幅 13.38%
- 历史最低 2.20
- 每 手 1
- 风险率 2.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 阿里、京东、英伟达、思科等获多家大行上调目标价；Doximity、Dynatrace、Enovix、Wix.com等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Autolus Therapeutics"买入"评级，目标价从9美元升至10美元；Maxim Group：维持Rezolute"买入"评级，目标价从4美元升至10美元
05-15 10:49
Maxim Group Maintains Buy on SeaStar Medical Holding, Raises Price Target to $8
Maxim Group analyst Anthony Vendetti maintains SeaStar Medical Holding (NASDAQ:ICU) with a Buy and raises the price target from $6 to $8.
05-15 04:45
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
On Wednesday, SeaStar Medical Holding (NASDAQ:ICU) discussed first-quarter fina...
05-14 05:20
SeaStar Medical Holding Q1 EPS $(0.90) Misses $(0.82) Estimate, Sales $495.000K Beat $437.500K Estimate
SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.82) by 9.76 percent. This is a 79.45 percent increase over losses of $(4.38) per
05-14 04:09
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026
SeaStar Medical announced new data from the SAVE Registry, showing no device-related adverse events and strong survival rates in pediatric patients with AKI and sepsis treated with its SCD therapy. In vitro research highlights the device's immunomodulatory effects, shifting monocytes to an anti-inflammatory state. The company also hosted a symposium on pediatric AKI innovation, underscoring its leadership in this field.
03-30 12:20
SeaStar Medical Holding Q4 EPS $(0.80) Beats $(1.01) Estimate, Sales $420.000K Beat $372.500K Estimate
SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.01) by 21.18 percent. This is a 91.11 percent increase over losses of $(9.00) per share
03-26 04:07
Earnings Scheduled For March 25, 2026
Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report q...
03-25 19:11
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026
SeaStar Medical Holding Corporation will report its Q4 and year-end 2025 financial results on March 25, 2026, and host a webcast and conference call at 4:30 p.m. ET to discuss its financial performance and business progress. The webcast and call registration details are available online. The company, focused on treating critically ill patients with organ failure, markets QUELIMMUNE (SCD-PED) for life-threatening AKI in pediatric patients and is c...
03-18 20:05
SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI
SeaStar Medical announced the completion of patient enrollment in the FDA-required SAVE Registry, a post-approval study to confirm the safety of QUELIMMUNE therapy for children with AKI due to sepsis. With 50 patients enrolled, the company will report 28-day safety data to the FDA later this year. QUELIMMUNE, approved in 2024, has shown promising results in clinical trials, including a 77% survival rate in treated patients, and is being used in l...
03-05 13:20
